Suppr超能文献

在乙胺丁醇所致视神经病变患者中,光学相干断层扫描检测到视网膜神经纤维层厚度降低。

Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.

作者信息

Chai Samantha J, Foroozan Rod

机构信息

Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin NC-205, Houston, TX 77030, USA.

出版信息

Br J Ophthalmol. 2007 Jul;91(7):895-7. doi: 10.1136/bjo.2006.113118. Epub 2007 Jan 10.

Abstract

BACKGROUND

It is difficult to assess the degree of optic nerve damage in patients with ethambutol-induced optic neuropathy, especially just after the onset of visual loss, when the optic disc typically looks normal.

AIM

To evaluate changes in retinal nerve fibre layer thickness (RNFLT) using optical coherence tomography (OCT) in patients with optic neuropathy within 3 months of cessation of ethambutol treatment.

DESIGN

A retrospective observational case series from a single neuro-ophthalmology practice.

METHODS

8 patients with a history of ethambutol-induced optic neuropathy were examined within 3 months after stopping ethambutol treatment. All patients underwent a neuro-ophthalmologic examination, including visual acuity, colour vision, visual fields and funduscopy. OCT was performed on both eyes of each patient using the retinal nerve fibre layer analysis protocol.

RESULTS

The interval between cessation of ethambutol treatment and the initial visit ranged from 1 week to 3 months. All patients had visual deficits characteristic of ethambutol-induced optic neuropathy at their initial visit, and the follow-up examination was performed within 12 months. Compared with the initial RNFLT, there was a statistically significant decrease in the mean RNFLT of the temporal, superior and nasal quadrants (p = 0.009, 0.019 and 0.025, respectively), with the greatest decrease in the temporal quadrant (mean decrease 26.5 mum).

CONCLUSIONS

A decrease in RNFLT is observed in all quadrants in patients with ethambutol-induced optic neuropathy who have recently discontinued the medication. This decrease is most pronounced in the temporal quadrant of the optic disc.

摘要

背景

对于乙胺丁醇所致视神经病变患者,很难评估其视神经损伤程度,尤其是在视力丧失刚出现时,此时视盘通常看起来正常。

目的

利用光学相干断层扫描(OCT)评估乙胺丁醇治疗停止后3个月内视神经病变患者视网膜神经纤维层厚度(RNFLT)的变化。

设计

来自单一神经眼科诊所的回顾性观察病例系列。

方法

8例有乙胺丁醇所致视神经病变病史的患者在停止乙胺丁醇治疗后3个月内接受检查。所有患者均接受了神经眼科检查,包括视力、色觉、视野和眼底镜检查。使用视网膜神经纤维层分析方案对每位患者的双眼进行OCT检查。

结果

乙胺丁醇治疗停止至初次就诊的间隔时间为1周-3个月。所有患者初次就诊时均有乙胺丁醇所致视神经病变的典型视力缺陷,并在12个月内进行了随访检查。与初始RNFLT相比,颞侧、上方和鼻侧象限的平均RNFLT有统计学显著下降(分别为p = 0.009、0.019和0.025),其中颞侧象限下降最大(平均下降26.5μm)。

结论

近期停用药物的乙胺丁醇所致视神经病变患者所有象限的RNFLT均下降。这种下降在视盘的颞侧象限最为明显。

相似文献

2
Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.
Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):410-6. doi: 10.1007/s00417-004-1053-1. Epub 2004 Nov 23.
3
Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography.
Ophthalmology. 2007 Dec;114(12):2338-44. doi: 10.1016/j.ophtha.2007.05.042. Epub 2007 Aug 27.
5
Prospective evaluation of visual function for early detection of ethambutol toxicity.
Br J Ophthalmol. 2009 Sep;93(9):1251-4. doi: 10.1136/bjo.2008.148502. Epub 2009 Jun 11.
10
Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography.
Eur J Ophthalmol. 2009 May-Jun;19(3):466-9. doi: 10.1177/112067210901900323.

引用本文的文献

2
Clinical profile and visual outcomes in ethambutol-induced toxic optic neuropathy.
Indian J Ophthalmol. 2025 Jun 1;73(Suppl 3):S484-S491. doi: 10.4103/IJO.IJO_1807_24. Epub 2025 May 30.
3
Ethambutol-Induced Optic Neuropathy: A Retrospective Study of Incidences and Risk Factors.
Cureus. 2025 Feb 17;17(2):e79160. doi: 10.7759/cureus.79160. eCollection 2025 Feb.
4
Factors affecting visual outcome in patients with toxic optic neuropathy caused by ethambutol.
Sci Rep. 2025 Feb 20;15(1):6257. doi: 10.1038/s41598-025-90663-3.
5
Utility of ganglion cells for the evaluation of anterior visual pathway pathology: a review.
Acta Neurol Belg. 2024 Aug;124(4):1113-1123. doi: 10.1007/s13760-024-02522-z. Epub 2024 Mar 27.
7
Ethambutol-induced optic neuropathy with rare bilateral asymmetry onset: A case report.
World J Clin Cases. 2022 Jan 14;10(2):663-670. doi: 10.12998/wjcc.v10.i2.663.
10
Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy.
PLoS One. 2019 Apr 17;14(4):e0215297. doi: 10.1371/journal.pone.0215297. eCollection 2019.

本文引用的文献

1
Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects.
Am J Ophthalmol. 2006 Oct;142(4):576-82. doi: 10.1016/j.ajo.2006.05.004.
2
Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.
Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):410-6. doi: 10.1007/s00417-004-1053-1. Epub 2004 Nov 23.
3
Ethambutol and optic neuropathy.
J Med Assoc Thai. 2003 Jul;86(7):622-5.
5
Reversibility of ethambutol optic neuropathy.
J Ocul Pharmacol Ther. 1997 Oct;13(5):473-7. doi: 10.1089/jop.1997.13.473.
6
Ocular ethambutol toxicity: is it reversible?
J Clin Neuroophthalmol. 1993 Mar;13(1):15-7.
7
Ocular toxicity following ethambutol in standard dosage.
Br J Dis Chest. 1986 Jul;80(3):288-91. doi: 10.1016/0007-0971(86)90066-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验